An AT1 receptor antagonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Fimasartan

Item No. 36524

Technical Information
Formal Name
2-butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-5-pyrimidineethanethioamide
CAS Number
247257-48-3
Synonyms
  • BR-A-657
Molecular Formula
C27H31N7OS
Formula Weight
Purity
≥98%
Formulation
A solid
DMF: 10 mg/mlDMSO: 20 mg/mlEthanol: 0.5 mg/ml
λmax
262 nm
SMILES
O=C1C(CC(N(C)C)=S)=C(C)N=C(CCCC)N1CC2=CC=C(C3=C(C4=NN=NN4)C=CC=C3)C=C2
InChi Code
InChI=1S/C27H31N7OS/c1-5-6-11-24-28-18(2)23(16-25(36)33(3)4)27(35)34(24)17-19-12-14-20(15-13-19)21-9-7-8-10-22(21)26-29-31-32-30-26/h7-10,12-15H,5-6,11,16-17H2,1-4H3,(H,29,30,31,32)
InChi Key
AMEROGPZOLAFBN-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Neutrophil Biology Wall Poster

    Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.

    DOWNLOAD NOW
    Product Description

    Fimasartan is an antagonist of the angiotensin II type 1 (AT1) receptor (IC50 = 0.16 nM in HEK293 cells expressing the human receptor).1 It is selective for the AT1- over the AT2 receptor (IC50 = 69 µM). Fimasartan (62.5, 125, and 250 µM) inhibits LPS-induced increases in inducible nitric oxide synthase (iNOS) levels and NO production, as well as NF-κB nuclear translocation in RAW 264.7 macrophages.2 It reduces angiotensin II-induced contractions of isolated rabbit aortic rings in a concentration-dependent manner.1 In vivo, fimasartan decreases mean arterial pressure in rats with hypertension induced by furosemide (Item No. 17273) and renal hypertensive rats when administered at doses of 10 and 0.3 mg/kg, respectively. Formulations containing fimasartan have been used in the treatment of hypertension.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Chi, Y.H., Lee, J.H., Kim, J.H., et alPharmacological characterization of BR-A-657, a highly potent nonpeptide angiotensin II receptor antagonist. Biol. Pharm. Bull. 36(7), 1208-1215 (2013).

    2. Ryu, S., Shin, J.-S., Cho, Y.-W., et alFimasartan, anti-hypertension drug, suppressed inducible nitric oxide synthase expressions via nuclear factor-kappa B and activator protein-1 inactivation. Biol. Pharm. Bull. 36(3), 467-474 (2013).